Thomas Delong

NIH Rank #1121
  • Rising Star
  • Program Award PI
  • R01 Award PI
  • Translational
  • Top 10% by Linked Awards
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9753886Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pharmacology

NIH Funding · FY2026

Linked Award Amount
$3M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#1,121
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Thomas Delong as a PI. Multi-PI records show the full award amount for context.

  • 4U01DK143495-02U01
    The Role of Granular Acidification in the Pathogenesis of Type 1 Diabetes
    $2M
    award amount
  • 5R01DK119529-09R01
    Characterize the Landscape and Origin of Hybrid Peptides in Beta Cells
    $529.6K
    award amount
  • 1R21AI196871-01R21
    Species-Specific Regulation of Autoantigen Processing: A Humanized Mouse Model of Cathepsin D in Type 1 Diabetes
    $429K
    award amount

Award organization

Organizations that administered FY2026 awards listing Thomas Delong as a PI.

FY2026 award administered by University of Colorado (CO).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    ScienceDex Coverage Begins
    Earliest loaded PI award records: FY2024
  2. 2024
    $500K Cumulative Linked Award Amount
  3. 2025
    $1M Cumulative Linked Award Amount
  4. 2025
    $2M Cumulative Linked Award Amount
  5. 2025
    Reached Top 50% by Award-Linked Rank
    Ranked #8039
  6. 2025
    R01 Award Record
  7. 2025
    Program or Center Award Record
  8. 2026
    $5M Cumulative Linked Award Amount
  9. 2026
    Reached Top 25% by Award-Linked Rank
    Ranked #1121
  10. 2026
    Reached Top 10% by Award-Linked Rank
    Ranked #1121